Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.56 EUR
89.24 M EUR
508.28 M EUR
74.86 M
About MYCRONIC AB
Sector
Industry
CEO
Per Anders Lindqvist
Website
Headquarters
Täby
Founded
1989
ISIN
SE0000375115
FIGI
BBG000D93PJ6
Mycronic AB engages in the development, manufacture, and sale of production equipment for electronics and display manufacturing. It operates through the following segments: Pattern Generators, High Flex, High Volume, and Global Technologies. The Pattern Generators segment specializes in the development, manufacture, and marketing of mask writers and measuring machines for production of photo masks for displays. The High Flex segment offers surface mount technology (SMT) and inspection equipment. The High Volume segment includes equipment for dispensing and conformal coating of circuit boards. The Global Technologies segment refers to the production solutions with differentiation. The company was founded in 1989 and is headquartered in Taby, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MYCRONIC AB SK 1 stocks are traded under the ticker MLT.
We've gathered analysts' opinions on MYCRONIC AB SK 1 future price: according to them, MLT price has a max estimate of 42.46 EUR and a min estimate of 38.25 EUR. Watch MLT chart and read a more detailed MYCRONIC AB SK 1 stock forecast: see what analysts think of MYCRONIC AB SK 1 and suggest that you do with its stocks.
Yes, you can track MYCRONIC AB SK 1 financials in yearly and quarterly reports right on TradingView.
MYCRONIC AB SK 1 is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
MLT earnings for the last quarter are 0.40 EUR per share, whereas the estimation was 0.32 EUR resulting in a 24.56% surprise. The estimated earnings for the next quarter are 0.29 EUR per share. See more details about MYCRONIC AB SK 1 earnings.
MYCRONIC AB SK 1 revenue for the last quarter amounts to 156.67 M EUR, despite the estimated figure of 138.75 M EUR. In the next quarter, revenue is expected to reach 150.48 M EUR.
MLT net income for the last quarter is 39.43 M EUR, while the quarter before that showed 25.16 M EUR of net income which accounts for 56.73% change. Track more MYCRONIC AB SK 1 financial stats to get the full picture.
Yes, MLT dividends are paid annually. The last dividend per share was 0.38 EUR. As of today, Dividend Yield (TTM)% is 1.12%. Tracking MYCRONIC AB SK 1 dividends might help you take more informed decisions.
MYCRONIC AB SK 1 dividend yield was 1.57% in 2023, and payout ratio reached 44.01%. The year before the numbers were 1.79% and 46.10% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 27, 2024, the company has 2.04 K employees. See our rating of the largest employees — is MYCRONIC AB SK 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MYCRONIC AB SK 1 EBITDA is 207.81 M EUR, and current EBITDA margin is 24.75%. See more stats in MYCRONIC AB SK 1 financial statements.
Like other stocks, MLT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYCRONIC AB SK 1 stock right from TradingView charts — choose your broker and connect to your account.